A randomised control study of metformin in people with mild cognitive impairment and without
diabetes mellitus to determine effects on cognitive decline and neuroimaging over 3 years.
Phase:
Phase 3
Details
Lead Sponsor:
Garvan Institute of Medical Research
Collaborator:
National Health and Medical Research Council, Australia